Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Mar 2024 09:35

RNS Number : 4585F
Indivior PLC
04 March 2024
 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

The relevant notification set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

The Company announces that it was notified on March 1, 2024, that the following Persons discharging managerial responsibilities ('PDMR') exercised an option over ordinary shares of $0.50 each in the Company ('Shares'). The number of shares exercised are outlined below.

Name

Date of Grant

Number of Shares

Exercise Priceper Share

Date of Exercise

Kathryn Hudson

December 4, 2020

1,875

£4.80

March 1, 2024

Hillel West

December 4, 2020

2,250

£4.80

March 1, 2024

Following the transactions, Kathryn Hudson retained her interest in the shares and holds a beneficial interest in 32,858 Shares. On March 1, 2024, Hillel West sold the shares resulting from the option exercise and holds a beneficial interest in 27,733 Shares.

Kathryn Hudson

Company Secretary

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Kathryn Hudson

2

 

Reason for the notification

 

a)

 

Position/status

  

PDMR - Company Secretary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Indivior PLC

b)

 

LEI

 

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Exercise of a share option under the ShareSave Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£4.80

1875

d)

 

Aggregated information

 

- Aggregated volume

 

 - Price

 

N/A

e)

 

Date of the transaction

March 1, 2024

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Hillel West

2

 

Reason for the notification

 

a)

 

Position/status

  

PDMR - Chief Manufacturing and Supply Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Indivior PLC

b)

 

LEI

 

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Exercise of a share option under the ShareSave Plan and sale of the resulting shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volumes(s)

1. £4.80

2,250

2. £17.61

2,250

d)

 

Aggregated information

 

- Aggregated volume

 

 - Price

 

N/A

e)

 

Date of the transaction

March 1, 2024

f)

 

Place of the transaction

 

1. Outside a trading venue

2. London Stock Exchange (XLON)

 

 

This notification is made in accordance with the requirements of the Market Abuse Regulation.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUCWWUPCUBC
Date   Source Headline
8th Jul 20164:30 pmRNSDividend Conversion Rate
28th Jun 20164:32 pmRNSDirector/PDMR Shareholding
16th Jun 201610:23 amRNSHolding(s) in Company
8th Jun 20165:10 pmRNSHolding(s) in Company
6th Jun 201612:19 pmRNSHolding(s) in Company
3rd Jun 20164:23 pmRNSIndivior welcomes Court ruling in ANDA litigation
1st Jun 20169:50 amRNSTotal Voting Rights
26th May 20165:33 pmRNSBuprenorphine Monthly Depot - FDA Fast Track
24th May 20163:45 pmRNSDirector/PDMR Shareholding
16th May 20163:00 pmRNSDirector/PDMR Shareholding
16th May 20161:45 pmRNSDirector/PDMR Shareholding
13th May 20161:31 pmRNSDirector/PDMR Shareholding
12th May 20164:13 pmRNSDirector/PDMR Shareholding
11th May 20165:50 pmRNSResult of AGM
4th May 20163:16 pmRNSAdditional Listing
3rd May 201612:00 pmRNS1st Quarter Results
28th Apr 20162:25 pmRNSResult of Phase 1 trial of RBP-6300
20th Apr 20162:00 pmRNSNotice of Results
15th Apr 20162:47 pmRNSHolding(s) in Company
8th Apr 20161:23 pmRNSAnnual Financial Report
7th Apr 20162:30 pmRNSDirectorate Change
11th Mar 20163:25 pmRNSHolding(s) in Company
11th Mar 20162:02 pmRNSDirectorate Change
22nd Feb 20163:41 pmRNSDirector/PDMR Shareholding
22nd Feb 201610:22 amRNSHolding(s) in Company
18th Feb 20167:00 amRNSPreliminary Full Year Results Announcement
15th Feb 201610:00 amRNSHolding(s) in Company
11th Feb 20169:17 amRNSParagraph IV Notification
9th Feb 20164:34 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSNotification of Full Year Results
24th Dec 20159:44 amRNSHolding(s) in Company
21st Dec 20154:26 pmRNSHolding(s) in Company
9th Dec 20154:29 pmRNSHolding(s) in Company
9th Dec 201512:45 pmRNSR&D Day & Preliminary Financial Guidance 2016
7th Dec 20157:00 amRNSRepurchase of $75m debt
2nd Dec 20151:28 pmRNSHolding(s) in Company
1st Dec 20152:03 pmRNSDirector/PDMR Shareholding
1st Dec 20158:43 amRNSHolding(s) in Company
24th Nov 20154:55 pmRNSFDA does not approve Naloxone Nasal Spray
4th Nov 20153:31 pmRNSDirector/PDMR Shareholding
3rd Nov 201512:00 pmRNS3rd Quarter Results
30th Oct 20153:08 pmRNSDirector/PDMR Shareholding
29th Oct 20158:42 amRNSHolding(s) in Company
28th Oct 20159:41 amRNSQ3 Conference Call on Tuesday, November 3 2015
19th Oct 20152:07 pmRNSHolding(s) in Company
12th Oct 20157:00 amRNSResponse to Court's decision on motion to amend
9th Oct 201512:00 pmRNS2015 Interim Dividend - Conversion Rate
6th Oct 201510:05 amRNSHolding(s) in Company
5th Oct 201510:00 amRNSParagraph IV Notification
1st Oct 20159:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.